A novel strategy for T cell vaccines

T细胞疫苗的新策略

• 批准号: nhmrc : GNT1084805
• 负责人: A/Pr Thomas Gebhardt
• 金额: $ 37.75万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/novel-strategy-t-cell-vaccines/1345582
• 关键词: novel; strategy; cell; vaccines

Current vaccines rely on immune components in the blood. We are taking a different approach, which focuses on immunity at the body surfaces. These are the areas where pathogens first gain access to the body and we have shown that immune cells in these regions are far more potent than those that need to be recruited from the circulation.

目前的疫苗依赖于血液中的免疫成分。我们正在采取一种不同的方法，侧重于身体表面的免疫。这些是病原体首先进入人体的区域，我们已经证明，这些区域的免疫细胞远比那些需要从循环中招募的免疫细胞更有效。